These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 19594790)

  • 1. Predictors of 3-month retention in a drug treatment therapeutic community.
    Mulder RT; Frampton CM; Peka H; Hampton G; Marsters T
    Drug Alcohol Rev; 2009 Jul; 28(4):366-71. PubMed ID: 19594790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retention, early dropout and treatment completion among therapeutic community admissions.
    Darke S; Campbell G; Popple G
    Drug Alcohol Rev; 2012 Jan; 31(1):64-71. PubMed ID: 21426420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mental health improvements of substance-dependent clients after 4 months in a Therapeutic Community.
    Polimeni AM; Moore SM; Gruenert S
    Drug Alcohol Rev; 2010 Sep; 29(5):546-50. PubMed ID: 20887579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Remission of psychiatric symptoms among drug misusers after drug dependence treatment.
    Gossop M; Marsden J; Stewart D
    J Nerv Ment Dis; 2006 Nov; 194(11):826-32. PubMed ID: 17102706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Client retention in residential drug treatment for Latinos.
    Amodeo M; Chassler D; Oettinger C; Labiosa W; Lundgren LM
    Eval Program Plann; 2008 Feb; 31(1):102-12. PubMed ID: 18222144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mindfulness-based stress reduction in therapeutic community treatment: a stage 1 trial.
    Marcus MT; Schmitz J; Moeller G; Liehr P; Cron SG; Swank P; Bankston S; Carroll DD; Granmayeh LK
    Am J Drug Alcohol Abuse; 2009; 35(2):103-8. PubMed ID: 19322731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Temperament and character dimensions in opiate addicts: comparing subjects who completed inpatient treatment in therapeutic communities vs. incompleters.
    Zoccali R; Muscatello MR; Bruno A; Bilardi F; De Stefano C; Felletti E; Isgrò S; Micalizzi V; Micò U; Romeo A; Meduri M
    Am J Drug Alcohol Abuse; 2007; 33(5):707-15. PubMed ID: 17891663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Programme factors that influence completion of residential treatment.
    Meier PS; Best D
    Drug Alcohol Rev; 2006 Jul; 25(4):349-55. PubMed ID: 16854661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Youth retention: factors associated with treatment drop-out from youth alcohol and other drug treatment.
    Schroder R; Sellman D; Frampton C; Deering D
    Drug Alcohol Rev; 2009 Nov; 28(6):663-8. PubMed ID: 19930021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Temperament, substance use and psychopathology in a prisoner population: implications for treatment.
    Allnutt S; Wedgwood L; Wilhelm K; Butler T
    Aust N Z J Psychiatry; 2008 Nov; 42(11):969-75. PubMed ID: 18941962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Social phobia in an outpatient alcohol and drug treatment sample.
    Adamson SJ; Sellman JD; Robertson PJ
    Aust N Z J Psychiatry; 2008 Feb; 42(2):134-40. PubMed ID: 18197508
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment process in the therapeutic community: associations with retention and outcomes among adolescent residential clients.
    Edelen MO; Tucker JS; Wenzel SL; Paddock SM; Ebener P; Dahl J; Mandell W
    J Subst Abuse Treat; 2007 Jun; 32(4):415-21. PubMed ID: 17481465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of a therapeutic community treatment program: a long-term follow-up study in Spain.
    Fernández-Montalvo J; López-Goñi JJ; Illescas C; Landa N; Lorea I
    Subst Use Misuse; 2008; 43(10):1362-77. PubMed ID: 18696373
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Attendance at Narcotics Anonymous and Alcoholics Anonymous meetings, frequency of attendance and substance use outcomes after residential treatment for drug dependence: a 5-year follow-up study.
    Gossop M; Stewart D; Marsden J
    Addiction; 2008 Jan; 103(1):119-25. PubMed ID: 18028521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drugs and Psychosis Project: a multi-centre European study on comorbidity.
    Baldacchino A; Blair H; Scherbaum N; Grosse-Vehne E; Riglietta M; Tidone L; Criaco C; Marelli MC; Sommer B; Tan L; Little H; Ghodse H
    Drug Alcohol Rev; 2009 Jul; 28(4):379-89. PubMed ID: 19594792
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Measuring changes in client-level treatment process in the therapeutic community (TC) with the Dimensions of Change Instrument (DCI).
    Paddock SM; Edelen MO; Wenzel SL; Ebener P; Mandell W; Dahl J
    Am J Drug Alcohol Abuse; 2007; 33(4):537-46. PubMed ID: 17668339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of 4-year outcome of community residential treatment for patients with substance use disorders.
    Laffaye C; McKellar JD; Ilgen MA; Moos RH
    Addiction; 2008 Apr; 103(4):671-80. PubMed ID: 18339113
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of psychiatric and substance use disorders among single mothers nearing lifetime welfare eligibility limits.
    Cook JA; Mock LO; Jonikas JA; Burke-Miller JK; Carter TM; Taylor A; Petersen CA; Grey DD; Gruenenfelder D
    Arch Gen Psychiatry; 2009 Mar; 66(3):249-58. PubMed ID: 19255374
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adolescents in therapeutic communities: retention and posttreatment outcome.
    Pompi KF
    NIDA Res Monogr; 1994; 144():128-61. PubMed ID: 8742609
    [No Abstract]   [Full Text] [Related]  

  • 20. Outcomes of mandated treatment for women with histories of abuse and co-occurring disorders.
    Clark C; Young MS
    J Subst Abuse Treat; 2009 Dec; 37(4):346-52. PubMed ID: 19394186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.